跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rispernov 2 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rispernov 2
Approved
STANDARD
Rispernov 2
Cubit Lifesciences LLP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3dbd5987e420bb3a
Company
Cubit Lifesciences LLP
Type
Standard
Approval Details
Approval Id
3dbd5987e420bb3a
Drug Approval Philippines Name
Rispernov 2
Product Name
Rispernov 2
Registration Number
DRP-15856
Brand Name
Rispernov 2
Generic Name
Risperidone
Dosage Form
Film-Coated Tablet
Dosage Strength
2 mg
Manufacturer
Cubit Lifesciences LLP
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
24 September 2024
Expiry Date
24 September 2029
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3dbd5987e420bb3a
Type
Standard
Back to Philippines FDA Approvals